The versatile heparin in COVID-19.

Clicks: 277
ID: 102891
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Coagulopathy in corona virus infection has been shown to be associated with high mortality with high D-dimers being a particularly important marker for the coagulopathy. In the latest paper from the same group, the use of anticoagulant therapy with heparin was shown to decrease mortality as well. This is especially so in patients i) who have met the sepsis induced coagulopathy (SIC) criteria ≥4 (40.0% vs 64.2%, P=0.029) compared to those with SIC score <4 (29.0% vs 22.6%, P=0.419).or ii) with markedly elevated D-dimer (greater than six-fold at the upper limit of normal).
Reference Key
thachil2020thejournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Thachil, Jecko;
Journal Journal of thrombosis and haemostasis : JTH
Year 2020
DOI
10.1111/jth.14821
URL
Keywords
coronavirus public policy pandemic

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.